Company intelligence / Profile preview

9305-9954 Quebec

Boucherville, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

CELEXT-07, a topical treatment for toenail onychomycosis, reached Phase 2 clinical trials. The study was a randomized, double-blind, placebo and active-controlled trial evaluating efficacy and safety over a year. The current status of the trial and results are not publicly available or are listed as "unknown".

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

CELEXT-07

Beyond the preview

Go deeper on 9305-9954 Quebec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9305-9954 Quebec.

Explore the full profile